
A systematic review updates randomized trial evidence on nebulized epinephrine for pediatric croup, focusing on short‑term symptom relief and hospitalization outcomes.
Key Takeaways
- Twelve randomized trials with 672 children were pooled in the meta-analysis
- Nebulized epinephrine produced a significant improvement in croup score at 30 minutes post‑treatment
- No sustained benefit was observed at 2 hours and hospital stay reduction was not statistically significant
